Trends in cause of death among patients with renal cell carcinoma in the United States: a SEER-based study

被引:0
作者
Xiangpeng Zhan
Tao Chen
Ying Liu
Hao Wan
Xiaoqiang Liu
Xinxi Deng
Bin Fu
Jing Xiong
机构
[1] The First Affiliated Hospital of Nanchang University,Department of Urology
[2] Hubei University of Medicine,Department of Preventive Medicine, School of Public Health
[3] Jiu Jiang No.1 People’s Hospital,Department of Urology
来源
BMC Public Health | / 23卷
关键词
Renal cell carcinoma; Cause of death; Trend; SEER; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 109 条
  • [1] Singh D(2021)Current updates and future perspectives on the management of renal cell carcinoma Life Sci 264 74-84
  • [2] Capitanio U(2019)Epidemiology of Renal Cell Carcinoma Eur Urol 75 9-29
  • [3] Bensalah K(2014)Cancer statistics, 2014 CA Cancer J Clin 64 124-140
  • [4] Bex A(2017)Beyond gastric adenocarcinoma: Multimodality assessment of common and uncommon gastric neoplasms Abdom Radiol (NY) 42 894-906
  • [5] Boorjian SA(2016)Renal cancer The Lancet 387 949-958
  • [6] Bray F(2008)The changing pattern of kidney cancer incidence and mortality in Europe BJU Int 101 2935-2944
  • [7] Coleman J(2019)Adjuvant therapy in renal cell carcinoma Cancer 125 2144-2150
  • [8] Siegel R(2010)Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival Journal of clinical oncology : official journal of the American Society of Clinical Oncology 28 127-137
  • [9] Ma J(2018)Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma Cancer Treat Rev 70 311-317
  • [10] Zou Z(2010)Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram Journal of clinical oncology : official journal of the American Society of Clinical Oncology 28 271-275